Increasing Prevalence of Pain-related Conditions will drive the market growth during the forecast period
LONDON–(BUSINESS WIRE)–#GlobalOvertheCounterOTCAnalgesicsMarket–The over the counter (OTC) analgesics market is expected to grow by USD 5.85 bn during 2020-2024, as per the latest research report by Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
Request for Technavio’s market report estimates including pre- and post-COVID-19 impact on over the counter (OTC) analgesics market. Download a Free Sample Report on the impact of COVID-19 pandemic analysis.
Due to the extensive spread of the virus across the globe, the Health Care Industry is anticipated to have Positive impact. The over the counter (OTC) analgesics market will showcase Neutral impact during 2020-2024.
Over the Counter (OTC) Analgesics Market 2020-2024: Segmentation
Over the Counter (OTC) Analgesics Market is segmented as below:
-
Type
- Internal OTC Analgesics
- External OTC Analgesics
-
Geography
- North America
- Europe
- Asia
- ROW
Asia region will account for the highest incremental growth during the forecast period due to the growing number of M&A activities.
With the surging growth of COVID-19 pandemic, the Health Care market is anticipated to have a Direct impact during the forecast period. View market snapshot before purchasing
A growing number of merger and acquisition (M&A) activities has been an instrumental factor in influencing the growth of over the counter (OTC) analgesics market. Other market drivers include growing number of launches of OTC analgesics. Technavio offers custom research analysis on the crucial pointers to highlight the impact of COVID-19 on the market across the supply chain.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID 19 market estimates
- Quarterly impact analysis and updates on market estimates
Get more insights about the global trends impacting the future of over the counter (OTC) analgesics market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR43442
Over the Counter (OTC) Analgesics Market 2020-2024: Vendor Analysis
The market is concentrated, and the degree of concentration will decelerate during the forecast period. Key players in the market have been launching several initiatives and introducing innovative products and services to cater a larger target audience during the pandemic. Major market participants include Bayer AG, Cipla Inc., GlaxoSmithKline Plc, Johnson & Johnson, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, and Sun Pharmaceutical Industries Ltd.
Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Table of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Internal – Market size and forecast 2019-2024
- External – Market size and forecast 2019-2024
- Market opportunity by Type
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver – Demand led growth
- Volume driver – Supply led growth
- Volume driver – External factors
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Bayer AG
- Cipla Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Perrigo Co. Plc
- Pfizer Inc.
- Piramal Enterprises Ltd.
- Reckitt Benckiser Group Plc
- Sanofi
- Sun Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/